NCT04088799View on ClinicalTrials.gov

LDL-Apheresis for FSGS CardioRenal Outcomes

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Focal Segmental Glomerulosclerosis
Interventions
OTHER

No intervention

No intervention

Trial Locations (2)

15224

Children's Hospital of Pittsburgh, Pittsburgh

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Kaneka Medical America LLC

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT04088799 - LDL-Apheresis for FSGS CardioRenal Outcomes | Biotech Hunter | Biotech Hunter